Nectar Lifesciences Limited - Laporan Laba Rugi (TTM)

Nectar Lifesciences Limited
IN ˙ NSEI
₹ 14.66 ↓ -0.03 (-0.20%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Nectar Lifesciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 20,291 17,586 15,433 15,387 14,765 15,421 16,689 16,868 17,109 16,120 15,237 15,148 15,241 16,322 16,846 16,493 16,792 16,814 16,704 15,918
Change (%) -13.33 -12.24 -0.30 -4.04 4.44 8.22 1.08 1.43 -5.78 -5.48 -0.58 0.62 7.09 3.21 -2.09 1.81 0.13 -0.66 -4.70
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 15,962 13,525 11,571 11,353 10,698 11,165 12,231 12,283 12,729 12,182 11,593 11,488 11,280 11,849 12,195 11,604 11,687 11,734 13,885 13,942
Change (%) -15.27 -14.45 -1.89 -5.77 4.36 9.55 0.42 3.63 -4.29 -4.84 -0.90 -1.82 5.05 2.92 -4.85 0.71 0.40 18.33 0.41
% of Revenue 78.66 76.91 74.98 73.78 72.46 72.40 73.29 72.82 74.40 75.57 76.08 75.84 74.01 72.60 72.39 70.36 69.60 69.78 83.12 87.59
Gross Operating Profit 4,329 4,061 3,862 4,034 4,067 4,256 4,457 4,585 4,380 3,938 3,644 3,659 3,961 4,472 4,650 4,889 5,106 5,080 2,819 1,976
Change (%) -6.20 -4.89 4.46 0.81 4.66 4.72 2.87 -4.46 -10.10 -7.46 0.42 8.25 12.90 3.98 5.13 4.43 -0.49 -44.51 -29.91
% of Revenue 21.34 23.09 25.02 26.22 27.54 27.60 26.71 27.18 25.60 24.43 23.92 24.16 25.99 27.40 27.61 29.64 30.40 30.22 16.88 12.41
SG&A 776 765 872 742 868 857 763 749 785 789 796 797 810 829 866 918 956 985 985 968
Change (%) -1.39 13.97 -14.83 16.85 -1.17 -10.99 -1.90 4.81 0.56 0.90 0.15 1.56 2.36 4.45 6.00 4.22 3.01 0.01 -1.79
% of Revenue 3.82 4.35 5.65 4.82 5.88 5.56 4.57 4.44 4.59 4.89 5.22 5.26 5.31 5.08 5.14 5.56 5.69 5.86 5.90 6.08
R&D
Change (%)
% of Revenue
OpEx 19,315 16,840 14,933 14,694 14,101 14,611 15,673 15,792 16,388 15,855 15,289 15,269 15,024 15,703 15,917 15,523 15,660 15,659 17,588 17,834
Change (%) -12.81 -11.32 -1.60 -4.03 3.61 7.27 0.76 3.77 -3.25 -3.57 -0.13 -1.60 4.52 1.36 -2.48 0.88 -0.01 12.32 1.40
% of Revenue 95.19 95.76 96.76 95.49 95.50 94.74 93.91 93.62 95.78 98.36 100.34 100.80 98.58 96.21 94.49 94.12 93.26 93.13 105.30 112.04
Operating Income 976 745 500 693 664 811 1,016 1,076 721 265 -52 -121 217 618 928 970 1,132 1,155 -885 -1,916
Change (%) -23.67 -32.93 38.71 -4.25 22.07 25.34 5.93 -32.98 -63.29 -119.53 133.54 -279.36 185.35 50.18 4.46 16.74 2.01 -176.60 116.58
% of Revenue 4.81 4.24 3.24 4.51 4.50 5.26 6.09 6.38 4.22 1.64 -0.34 -0.80 1.42 3.79 5.51 5.88 6.74 6.87 -5.30 -12.04
Interest Expense -834 -830 -858 -1,099 -738 -608 -699 -744 -685 -684 -828 -791 -786 -860 -896 -920 -913 -835 -771 -733
Change (%) -0.53 3.37 28.15 -32.88 -17.64 15.12 6.42 -7.90 -0.23 21.07 -4.52 -0.60 9.39 4.27 2.63 -0.77 -8.46 -7.77 -4.88
% of Revenue -4.11 -4.72 -5.56 -7.14 -5.00 -3.94 -4.19 -4.41 -4.01 -4.24 -5.43 -5.22 -5.16 -5.27 -5.32 -5.58 -5.43 -4.97 -4.61 -4.60
Net Income -86 -249 -733 -546 -454 -276 250 272 28 -162 -242 -263 -28 81 50 61 107 170 -1,137 -1,799
Change (%) 189.82 194.59 -25.52 -16.81 -39.22 -190.79 8.40 -89.62 -674.59 49.28 8.60 -89.43 -391.16 -38.18 23.00 74.61 58.48 -768.68 58.23
% of Revenue -0.42 -1.41 -4.75 -3.55 -3.07 -1.79 1.50 1.61 0.16 -1.00 -1.59 -1.73 -0.18 0.50 0.30 0.37 0.64 1.01 -6.81 -11.30

Source: Capital IQ

Other Listings
IN:532649
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista